Does TENAPANOR Cause Therapy interrupted? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Therapy interrupted have been filed in association with TENAPANOR (IBSRELA). This represents 2.7% of all adverse event reports for TENAPANOR.
52
Reports of Therapy interrupted with TENAPANOR
2.7%
of all TENAPANOR reports
1
Deaths
24
Hospitalizations
How Dangerous Is Therapy interrupted From TENAPANOR?
Of the 52 reports, 1 (1.9%) resulted in death, 24 (46.2%) required hospitalization, and 1 (1.9%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENAPANOR. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does TENAPANOR Cause?
Diarrhoea (793)
Death (222)
Hospitalisation (138)
Inappropriate schedule of product administration (115)
Off label use (94)
Product use issue (72)
Nausea (59)
Abdominal distension (52)
Abdominal pain (50)
Product use in unapproved indication (47)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which TENAPANOR Alternatives Have Lower Therapy interrupted Risk?
TENAPANOR vs TENECTEPLASE
TENAPANOR vs TENELIGLIPTIN
TENAPANOR vs TENIPOSIDE
TENAPANOR vs TENOFOVIR
TENAPANOR vs TENOFOVIR ALAFENAMIDE